Quetiapine Use During Pregnancy: What Do We Know About Reproductive Safety?
For women who require treatment with quetiapine during pregnancy, the available reproductive safety data are generally reassuring. The largest body of evidence does not suggest a meaningful increase in major congenital malformations, while metabolic effects, particularly gestational diabetes, remain an important consideration.
September is Suicide Prevention Awareness Month: Emergency Resources for Individuals with Perinatal Mental Health Issues
If you or someone you know is in crisis, confidential support is available.
Weekly Roundup for September 4, 2026: Recent Publications in Women’s Mental Health
Suicide risk during pregnancy and the postpartum, use of modafinil in pregnancy, and new treatment for menopausal symptoms are featured in this week’s roundup.
Atomoxetine and Stimulants During Pregnancy: What Do We Know About Pregnancy Outcomes?
A new study examines pregnancy outcomes among women using stimulants or atomoxetine during pregnancy, finding modest increases in some complications with stimulant use while highlighting important limitations of observational data.
ADHD Stimulants and Pregnancy: New Study Examines Risks of Continued Treatment
A large claims-based study found no increased risk for most outcomes with first-trimester stimulant exposure during pregnancy, but higher risks when use continued later in pregnancy.
Lamotrigine and Menopausal Hormone Therapy: What Women Need to Know
Estrogen-containing menopausal hormone therapy (MHT) may lower blood levels of lamotrigine, potentially reducing its effectiveness in some women with bipolar disorder. What do we know about this interaction, and does the risk differ with oral, transdermal, or vaginal estrogen?